New oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease (Q24192938)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	New oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease	scientific article

Statements

scholarly article

0 references

New oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease (English)

0 references

atrial fibrillation

0 references

anticoagulation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Shunichi Fukuhara

5

object named as

Shunichi Fukuhara

0 references

author name string

Miho Kimachi

1

0 references

Toshi A Furukawa

2

0 references

Kimihiko Kimachi

3

0 references

Yoshihito Goto

4

0 references

publication date

10 November 2014

0 references

Cochrane Database of Systematic Reviews

0 references

Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

The efficacy and safety of oral anticoagulants in warfarin-suitable patients with nonvalvular atrial fibrillation: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

Impact of chronic kidney disease on risk of incident atrial fibrillation and subsequent survival in medicare patients

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

Preventing stroke in patients with chronic kidney disease and atrial fibrillation: benefit and risks of old and new oral anticoagulants

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011373

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD011373

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24192938&oldid=1947457367"